Jinyu Bio-Technology CoSHSE:600201 +3.58%68 ROA % is 4.91% as of Mar. 2026, which is 4% below its 10-year median of 5.11. GuruFocus rates SHSE:600201 with a GF Score™ of 68/100 and a GF Value™ of ¥8.19 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,419 Biotechnology companies, Jinyu Bio-Technology Co ranks better than 82.88% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Jinyu Bio-Technology Co's annualizedNet Income for the quarter that ended in Mar. 2026 was ¥323 Mil.
Jinyu Bio-Technology Co's average Total Assets over the quarter that ended in Mar. 2026 was ¥6,574 Mil. Therefore, Jinyu Bio-Technology Co's annualized ROA % for the quarter that ended in Mar. 2026 was 4.91%.
The historical rank and industry rank for Jinyu Bio-Technology Co's ROA % or its related term are showing as below:
SHSE:600201'
s ROA % Range Over the Past 10 Years
Min: 1.5 Med: 5.11 Max: 18.69
Current: 1.57
During the past 13 years, Jinyu Bio-Technology Co's highest ROA % was 18.69%. The lowest was 1.50%. And the median was 5.11%.
SHSE:600201's ROA % is ranked better than 82.88% of 1419
companies
in the Biotechnology industry
Industry Median: -32.84
vs SHSE:600201: 1.57
Jinyu Bio-Technology Co (SHSE:600201) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Jinyu Bio-Technology Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinyu Bio-Technology Co ROA % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jinyu Bio-Technology Co's ROA % distribution charts can be found below:
* The bar in red indicates where Jinyu Bio-Technology Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Jinyu Bio-Technology Co (SHSE:600201) has a ROA % of 4.91% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Jinyu Bio-Technology Co and its competitors. This is near median its historical median of 5.11. Over the past decade, Jinyu Bio-Technology Co's ROA % has ranged from 1.50 to 18.69. According to the industry distribution chart, Jinyu Bio-Technology Co ranks #243 out of 1419 companies in the Biotechnology industry, placing it in the top 17.1%.
Is Jinyu Bio-Technology Co's ROA % too high?
Jinyu Bio-Technology Co's current ROA % of 4.91% is near median its 10-year median of 5.11. Over the past 10 years, this metric has ranged from a low of 1.50 to a high of 18.69. Based on the distribution chart, Jinyu Bio-Technology Co ranks #243 out of 1419 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Jinyu Bio-Technology Co has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinyu Bio-Technology Co's ROA % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Jinyu Bio-Technology Co ranks #243 out of 1419 companies for ROA %. This places Jinyu Bio-Technology Co in the top 17% of its industry — outperforming the majority of peers. Historically, Jinyu Bio-Technology Co's own ROA % has ranged from 1.50 to 18.69 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Jinyu Bio-Technology Co and its competitors. Jinyu Bio-Technology Co's current ROA % is 4.91%, which is near median its own 10-year median of 5.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinyu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co (SHSE:600201) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥8.19, compared to a current price of ¥11.85 — trading 44.7% above its estimated fair value. The current ROA % is 4.91%, which is near median its 10-year median of 5.11. Jinyu Bio-Technology Co's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Jinyu Bio-Technology Co (SHSE:600201), the current ROA % is 4.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinyu Bio-Technology Co (SHSE:600201) Overvalued in 2026?
Based on GuruFocus' analysis, Jinyu Bio-Technology Co stock appears to be overvalued.
The current stock price of ¥11.85 is trading 44.7% above its estimated GF Value™ of ¥8.19.
GuruFocus considers Jinyu Bio-Technology Co to be Significantly Overvalued.
Key valuation signals for SHSE:600201:
ROA %: 4.91% (near median its 10-year median of 5.11)
GF Value™: ¥8.19 vs. price of ¥11.85 (44.7% above fair value)
No single metric tells the full story. See the SHSE:600201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
68GF Score
Get the complete analysis for SHSE:600201
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600201 has been successfully added to your 
